Cannell Capital - PSYCHEMEDICS CORP ownership

PSYCHEMEDICS CORP's ticker is PMD and the CUSIP is 744375205. A total of 21 filers reported holding PSYCHEMEDICS CORP in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Cannell Capital ownership history of PSYCHEMEDICS CORP
ValueSharesWeighting
Q1 2023$392,668
+7.0%
74,7940.0%0.08%
+2.7%
Q4 2022$366,842
-36.2%
74,794
-16.2%
0.07%
-43.9%
Q3 2022$575,000
+1.6%
89,2110.0%0.13%
+15.8%
Q2 2022$566,000
+4.8%
89,211
+13.9%
0.11%
+39.0%
Q1 2022$540,000
+8.4%
78,306
+10.3%
0.08%
+3.8%
Q4 2021$498,00071,0000.08%
Other shareholders
PSYCHEMEDICS CORP shareholders Q1 2023
NameSharesValueWeighting ↓
WEALTH EFFECTS LLC 44,501$233,6290.12%
SANTA MONICA PARTNERS LP 20,000$1050.08%
Cannell Capital 74,794$392,6680.08%
RBF Capital, LLC 144,231$757,2130.06%
CRAWFORD INVESTMENT COUNSEL INC 256,349$1,345,8300.03%
Ancora Advisors, LLC 78,373$411,4570.01%
WEDBUSH SECURITIES INC 29,418$1540.01%
Renaissance Technologies 281,263$1,4770.00%
FMR LLC 100$5250.00%
DIMENSIONAL FUND ADVISORS LP 56,562$296,9510.00%
View complete list of PSYCHEMEDICS CORP shareholders